Affimed to Present at the Leerink Partners 6th Annual Global Healthcare Conference
February 08 2017 - 5:01AM
Heidelberg, Germany, February 8, 2017 - Affimed
N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company
focused on discovering and developing highly targeted cancer
immunotherapies, announced today that Dr. Adi Hoess, CEO, will
present at the Leerink Partners 6th Annual Global Healthcare
Conference on Wednesday, February 15, 2017 at 9:00 a.m. (ET) in New
York.
A live webcast of the conference presentation
can be accessed through the "Events" section on the "Media" page of
the Affimed website at http://www.affimed.com/events.php. A replay
of the presentation will be available from Affimed's website for 30
days following the respective conference.
About Affimed N.V.
Affimed (Nasdaq: AFMD) engineers targeted
immunotherapies, seeking to cure patients by harnessing the power
of innate and adaptive immunity (NK- and T-cells). We are
developing single and combination therapies to treat cancers and
other life-threatening diseases. For more information, please visit
www.affimed.com.
IR Contact:
Caroline Stewart, Head IRPhone: +1 347394 6793E-Mail:
IR@affimed.com or c.stewart@affimed.com
Media Contact:
Anca Alexandru, Head of Communications, EU IRPhone: +49 6221
64793341E-Mail: a.alexandru@affimed.com
Affimed NV (NASDAQ:AFMD)
Historical Stock Chart
From Apr 2024 to May 2024
Affimed NV (NASDAQ:AFMD)
Historical Stock Chart
From May 2023 to May 2024